Home LiteratureArticle Details
PMID: 15640443 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation.

Nucleic acids research ·Vol. 33 ·No. 1 ·2005-00-00 ·Pages 13-26

Gaughan L, Logan IR, Neal DE, Robson CN

Abstract

The androgen receptor (AR) is a member of the nuclear hormone receptor family of transcription factors and plays a critical role in regulating the expression of genes involved in androgen-dependent and -independent tumour formation. Regulation of the AR is achieved by alternate binding of either histone acetyltransferase (HAT)-containing co-activator proteins, or histone deacetylase 1 (HDAC1). Factors that control AR stability may also constitute an important regulatory mechanism, a notion that has been confirmed with the finding that the AR is a direct target for Mdm2-mediated ubiquitylation and proteolysis. Using chromatin immunoprecipitation (ChIP) and re-ChIP analyses, we show that Mdm2 associates with AR and HDAC1 at the active androgen-responsive PSA promoter in LNCaP prostate cancer cells. Furthermore, we demonstrate that Mdm2-mediated modification of AR and HDAC1 catalyses protein destabilization and attenuates AR sactivity, suggesting that ubiquitylation of the AR and HDAC1 may constitute an additional mechanism for regulating AR function. We also show that HDAC1 and Mdm2 function co-operatively to reduce AR-mediated transcription that is attenuated by the HAT activity of the AR co-activator Tip60, suggesting interplay between acetylation status and receptor ubiquitylation in AR regulation. In all, our data indicates a novel role for Mdm2 in regulating components of the AR transcriptosome.

MeSH Terms
Androgens/pharmacology Animals COS Cells Cell Line, Tumor Chlorocebus aethiops Down-Regulation Histone Deacetylases/metabolism Nuclear Proteins/antagonists & inhibitors,physiology Promoter Regions, Genetic Proto-Oncogene Proteins/antagonists & inhibitors,physiology Proto-Oncogene Proteins c-abl/metabolism Proto-Oncogene Proteins c-mdm2 Receptors, Androgen/metabolism Ubiquitins/metabolism
Chemicals
Androgens Nuclear Proteins Proto-Oncogene Proteins Receptors, Androgen Ubiquitins Proto-Oncogene Proteins c-mdm2 Proto-Oncogene Proteins c-abl Histone Deacetylases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gaughan Luke
Prostate Research Group, Northern Institute for Cancer Research Paul, O'Gorman Building University of Newcastle Upon Tyne, Medical School Framlington Place, Newcastle Upon Tyne NE2 4HH, UK.
Logan Ian R
Neal David E
Robson Craig N
References (56)
56 references, click to expand
  1. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
    J Biol Chem. 2000 Mar 24;275(12):8945-51 PMID: 10722742
  2. Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.
    Mol Cell Biol. 2003 Aug;23(16):5867-81 PMID: 12897156
  3. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation.
    J Biol Chem. 2000 Jul 7;275(27):20853-60 PMID: 10779504
  4. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
    Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12009-14 PMID: 14507994
  5. Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8.
    Genes Dev. 2003 Nov 1;17(21):2648-63 PMID: 14563679
  6. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain.
    J Biol Chem. 1999 Dec 24;274(52):37219-25 PMID: 10601285
  7. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.
    Mol Cell Biol. 2003 Dec;23(23):8563-75 PMID: 14612401
  8. Back to the future with ubiquitin.
    Cell. 2004 Jan 23;116(2):181-90 PMID: 14744430
  9. Rad6 plays a role in transcriptional activation through ubiquitylation of histone H2B.
    Genes Dev. 2004 Jan 15;18(2):184-95 PMID: 14752010
  10. Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription?
    Mol Endocrinol. 2004 Mar;18(3):493-9 PMID: 14673136
  11. TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination.
    J Biol Chem. 2004 Apr 23;279(17):17524-34 PMID: 14761944
  12. MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.
    J Biol Chem. 2004 May 7;279(19):20035-43 PMID: 14769800
  13. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.
    J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):665-9 PMID: 1562539
  14. Androgen receptor and mechanism of androgen action.
    Ann Med. 1993 Feb;25(1):83-9 PMID: 8435194
  15. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
    Mol Endocrinol. 1996 Dec;10(12):1582-94 PMID: 8961268
  16. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
    Mol Endocrinol. 1997 Apr;11(4):450-9 PMID: 9092797
  17. Histone deacetylase activity is required for full transcriptional repression by mSin3A.
    Cell. 1997 May 2;89(3):341-7 PMID: 9150133
  18. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
    Cell. 1997 Aug 22;90(4):595-606 PMID: 9288740
  19. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3519-24 PMID: 9520398
  20. Co-activators and co-repressors in the integration of transcriptional responses.
    Curr Opin Cell Biol. 1998 Jun;10(3):373-83 PMID: 9640539
  21. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
    Mol Cell Biol. 1999 Feb;19(2):1202-9 PMID: 9891054
  22. Proteasome-dependent degradation of the human estrogen receptor.
    Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1858-62 PMID: 10051559
  23. c-Abl neutralizes the inhibitory effect of Mdm2 on p53.
    J Biol Chem. 1999 Mar 26;274(13):8371-4 PMID: 10085066
  24. Tip60 is a nuclear hormone receptor coactivator.
    J Biol Chem. 1999 Jun 18;274(25):17599-604 PMID: 10364196
  25. Mechanisms of androgen receptor activation and function.
    J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):307-13 PMID: 10419007
  26. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.
    Mol Cell. 2000 Jun;5(6):939-48 PMID: 10911988
  27. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
    Mol Endocrinol. 2000 Aug;14(8):1162-74 PMID: 10935541
  28. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.
    J Biol Chem. 2000 Jul 28;275(30):22986-94 PMID: 10816582
  29. The contribution of the RING finger domain of MDM2 to cell cycle progression.
    Oncogene. 2000 Aug 10;19(34):3849-57 PMID: 10951578
  30. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels.
    Biochem Biophys Res Commun. 2000 Sep 16;276(1):144-50 PMID: 11006097
  31. Androgen receptor--an update of mechanisms of action in prostate cancer.
    Urol Res. 2000 Aug;28(4):211-9 PMID: 11011957
  32. Molecular genetics of prostate cancer.
    Genes Dev. 2000 Oct 1;14(19):2410-34 PMID: 11018010
  33. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.
    J Biol Chem. 2000 Nov 10;275(45):35256-63 PMID: 10938272
  34. Androgen receptor signalling in the prostate.
    BJU Int. 2000 Dec;86(9):1001-13 PMID: 11119093
  35. From ligand to response: generating diversity in nuclear receptor coregulator function.
    J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):351-6 PMID: 11162944
  36. Protein regulation by monoubiquitin.
    Nat Rev Mol Cell Biol. 2001 Mar;2(3):195-201 PMID: 11265249
  37. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
    Oncogene. 2001 Mar 15;20(11):1267-75 PMID: 11313871
  38. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.
    Mol Cell Biol. 2001 Sep;21(17):5869-78 PMID: 11486026
  39. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.
    J Biol Chem. 2001 Nov 16;276(46):42714-21 PMID: 11555652
  40. Histone ubiquitination: a tagging tail unfolds?
    Bioessays. 2002 Feb;24(2):166-74 PMID: 11835281
  41. Nuclear receptor coregulators: multiple modes of modification.
    Trends Endocrinol Metab. 2002 Mar;13(2):55-60 PMID: 11854019
  42. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation.
    EMBO J. 2002 Apr 2;21(7):1704-12 PMID: 11927554
  43. Formation of the androgen receptor transcription complex.
    Mol Cell. 2002 Mar;9(3):601-10 PMID: 11931767
  44. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities.
    J Biol Chem. 2002 Jun 28;277(26):23658-63 PMID: 11960997
  45. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.
    EMBO J. 2002 Jul 15;21(14):3715-27 PMID: 12110584
  46. Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor.
    J Biol Chem. 2002 Jul 19;277(29):25904-13 PMID: 11994312
  47. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase.
    EMBO J. 2002 Aug 1;21(15):4037-48 PMID: 12145204
  48. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells.
    J Biol Chem. 2002 Sep 27;277(39):36570-6 PMID: 12119296
  49. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
    EMBO J. 2002 Nov 15;21(22):6236-45 PMID: 12426395
  50. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.
    J Biol Chem. 2002 Dec 13;277(50):48366-71 PMID: 12376534
  51. Acetylation of p53 inhibits its ubiquitination by Mdm2.
    J Biol Chem. 2002 Dec 27;277(52):50607-11 PMID: 12421820
  52. Regulating the regulators: lysine modifications make their mark.
    Cell. 2003 Jan 10;112(1):11-7 PMID: 12526789
  53. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.
    Mol Cell. 2003 Mar;11(3):695-707 PMID: 12667452
  54. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex.
    EMBO J. 2003 May 1;22(9):2135-45 PMID: 12727880
  55. When ubiquitin meets ubiquitin receptors: a signalling connection.
    Nat Rev Mol Cell Biol. 2003 Jun;4(6):491-7 PMID: 12778128
  56. Ubiquitin-mediated proteolysis: biological regulation via destruction.
    Bioessays. 2000 May;22(5):442-51 PMID: 10797484
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
1362-4962
Published
2005-00-00
Epub
2005-00-07
Pages
13-26
Language
English
Region
England
NLM ID
0411011
PMCID
PMC546130
Subset
IM
Grants
Medical Research Council · G0100100 · United Kingdom
Corrections
ErratumIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]